Accelerated long‐term forgetting over three months in asymptomatic APOE ɛ4 carriers

Accelerated long‐term forgetting (ALF) refers to a rapid loss of information over days or weeks despite normal acquisition/encoding. Notwithstanding its potential relevance as a presymptomatic marker of cognitive dysfunction, no study has addressed the relationship between ALF and Alzheimer’s disease (AD) biomarkers. We examined ALF in APOE ɛ4 carriers versus noncarriers, and its relationships with AD cerebrospinal fluid (CSF) biomarkers. We found ALF over three months in APOE ɛ4 carriers (F(1,19) = 5.60; P < 0.05; Cohen’s d = 1.08), and this performance was associated with abnormal levels of the CSF Aβ42/ptau ratio (r = −.614; P < 0.01). Our findings indicate that ALF is detectable in at‐risk individuals, and that there is a relationship between ALF and the pathophysiological processes underlying AD.

[1]  Jacqueline F Zimmermann,et al.  Accelerated long-term forgetting in asymptomatic APOE ε4 carriers , 2018, The Lancet Neurology.

[2]  Nick C Fox,et al.  Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study , 2018, The Lancet Neurology.

[3]  R. Morris,et al.  Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice , 2016, Nature Communications.

[4]  Rebecca A Betensky,et al.  Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease , 2014, Neurology.

[5]  C R Jack,et al.  Spotlight on the January 24 Issue , 2012, Neurology.

[6]  Riitta Salmelin,et al.  Neurocognition of New Word Learning in the Native Tongue: Lessons From the Ancient Farming Equipment Paradigm , 2010 .

[7]  F. Jessen,et al.  Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. , 2010, Archives of general psychiatry.

[8]  Wei Zhu,et al.  Outcome over seven years of healthy adults with and without subjective cognitive impairment , 2010, Alzheimer's & Dementia.

[9]  J. Wixted,et al.  Genuine power curves in forgetting: A quantitative analysis of individual subject forgetting functions , 1997, Memory & cognition.

[10]  J. Wixted,et al.  On the Form of Forgetting , 1991 .

[11]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[12]  P. Rubé,et al.  L’examen Clinique en Psychologie , 1959 .

[13]  C. Jack,et al.  Framework : Towards a Biological Definition of Alzheimer ’ s Disease 1 2 draft 9-19-17 3 4 5 , 2017 .

[14]  J. Molinuevo,et al.  Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1. , 2017, Journal of Alzheimer's disease : JAD.

[15]  J. Molinuevo,et al.  The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study. , 2014, Journal of Alzheimer's disease : JAD.

[16]  J. Molinuevo,et al.  [Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer's disease]. , 2011, Revista de neurologia.

[17]  D. Rubin,et al.  One Hundred Years of Forgetting : A Quantitative Description of Retention , 1996 .